Skip to main content
Erschienen in: Cardiovascular Drugs and Therapy 2/2009

Open Access 01.04.2009 | Editorial

Tomato Extract for Hypertension?

Editorial to “The Effects of Natural Antioxidants from Tomato Extract in Treated but Uncontrolled Hypertensive Patients” by E. Paran et al.

verfasst von: Peter W. de Leeuw, Aalt Bast

Erschienen in: Cardiovascular Drugs and Therapy | Ausgabe 2/2009

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
In this issue of Cardiovascular Drugs and Therapy, professor Paran and her colleagues report on the beneficial effect of tomato extract on blood pressure in patients who were insufficiently controlled with antihypertensive drugs [1]. In a randomized, placebo-controlled, double-blind cross-over trial they compared the extract to placebo in 50 hypertensive patients who had already been treated with a variety of drugs. While placebo did not have a measurable effect on blood pressure, the extract caused a fall of approximately 13/4 mmHg. The magnitude of this result is comparable to what the same investigators found earlier in a group of untreated subjects with mild hypertension [2]. Taken together, this suggests that the use of antihypertensive agents as in the current study did not modify the hypotensive potential of the extract. This makes the observations even more clinically meaningful and it certainly adds a new tool to the array of life-style interventions which we frequently recommend to our patients. A strong point in the study is that blood pressure was always measured with an automatic device.
Nevertheless, it should also be noted that a substantial portion of the study population was over 65 years of age. As ageing is generally thought to be associated with increased oxidative stress, it may be that there is more to be gained with antioxidant therapy in the elderly than in the young. Whether the beneficial effects of tomato extract can be extrapolated to patients with less advanced age, thus remains to be determined. It would also be interesting to know whether a high baseline intake of antioxidant substances from whatever source would enhance or just mitigate the response to the extract.
Although Paran and associates have carefully executed their study, there is a point of concern. In fact, the degree of blood pressure changes that they observed is greater than what one would expect. With a baseline blood pressure of, on average, 139/80 mmHg when the two groups were combined one would not anticipate a change in systolic pressure of 10 mmHg or more. Even the most powerful drugs usually do not produce that effect. One wonders, therefore, whether other factors could have contributed to the decline in pressure. Indeed, with other life-style measures such as a high intake of fruit and vegetables gave a fall in blood pressure of ‘only’ 4 mmHg systolic and 1.5 mmHg diastolic was observed [3]. Nevertheless, if at the population level the intake of tomatoes or tomato extract would increase to match that in the Paran study and if the population mean of blood pressure would fall to the same or perhaps a lesser extent, this would have enormous consequences in terms of reduction of cardiovascular risk.
Despite the clear-cut effects of the tomato extract, it remains enigmatic why it lowers blood pressure so profoundly. Direct effects on blood pressure of lycopene, beta-carotene, folate, vitamin C and vitamin E have not been described. However, tomatoes are rich in potassium, which is known to reduce blood pressure. Tomatoes also contain polyphenolic compounds, the flavonoids. Recently, we found that tomato paste lowers blood pressure in spontaneously hypertensive rats (unpublished data). This effect was greater when we administered tomato paste obtained from transgenic tomatoes which had a higher concentration of the flavonoid quercetin-glycoside, rutin. Several mechanisms have been suggested that could explain this effect of flavonoids. Flavonoids can protect the vasorelaxant NO radical from reaction with the superoxide anion radical (O2 ●−) because these polyphenols are scavengers of O2 ●−. In this way not only the NO effect is preserved but also the formation of the very reactive damaging peroxynitrite molecule is prevented. Flavonoids can efficiently scavenge the damaging peroxynitrite [4]. They are also known to inhibit the O2 ●− producing enzyme xanthine oxidase [5]. Finally, polyphenols may increase the availability of l-arginine, which can be a rate-limiting factor for the production of NO, by inhibiting arginase activity [6]. Antioxidants act synergistically, i.e. their combined effect is larger than the sum of the individual components. It will be interesting to see whether the tomato contains such a synergistic combination of compounds.
The treatment period in the study of Paran and her colleagues was 6 weeks. Therefore, also long-term effects of tomato consumption should be investigated, e.g. on gene expression profiles.
In a recent editorial, Barnes stated that there is a case for broccoli to be used in COPD as a way to compensate for defective antioxidant regulation [7]. Similarly, there may be a case for tomatoes to be applied in the treatment of hypertension. If more of these natural treatment modalities are shown to be effective, we may wonder whether the diet of tomorrow will turn to be the pharmacotherapy of the future.

Open Access

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Open AccessThis is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License (https://​creativecommons.​org/​licenses/​by-nc/​2.​0), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
download
DOWNLOAD
print
DRUCKEN

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Jetzt e.Med zum Sonderpreis bestellen!

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Jetzt bestellen und 100 € sparen!

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

Jetzt bestellen und 100 € sparen!

Literatur
1.
Zurück zum Zitat Paran E, Novack V, Engelhard YN, Hazan-Halevy I. The effects of natural antioxidants from tomato extract in treated but uncontrolled hypertensive patients. Cardiovasc Drugs Ther. 2009;23: this issue. Paran E, Novack V, Engelhard YN, Hazan-Halevy I. The effects of natural antioxidants from tomato extract in treated but uncontrolled hypertensive patients. Cardiovasc Drugs Ther. 2009;23: this issue.
2.
Zurück zum Zitat Engelhard YN, Gazer B, Paran E. Natural antioxidants from tomato extract reduce blood pressure in patients with grade-1 hypertension: a double-blind, placebo-controlled pilot study. Am Heart J 2006;151:100.PubMedCrossRef Engelhard YN, Gazer B, Paran E. Natural antioxidants from tomato extract reduce blood pressure in patients with grade-1 hypertension: a double-blind, placebo-controlled pilot study. Am Heart J 2006;151:100.PubMedCrossRef
3.
Zurück zum Zitat John JH, Ziebland S, Yudkin P, Roe LS, Nell HAW. Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: a randomised controlled trial. Lancet 2002;359:1969.PubMedCrossRef John JH, Ziebland S, Yudkin P, Roe LS, Nell HAW. Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: a randomised controlled trial. Lancet 2002;359:1969.PubMedCrossRef
4.
Zurück zum Zitat Haenen GRMM, Paquay JB, Korthouwer RE, Bast A. Peroxynitrite scavenging by flavonoids. Biochem Biophys Res Commun 1997;236:591.PubMedCrossRef Haenen GRMM, Paquay JB, Korthouwer RE, Bast A. Peroxynitrite scavenging by flavonoids. Biochem Biophys Res Commun 1997;236:591.PubMedCrossRef
5.
Zurück zum Zitat van Hoorn DEC, Nijvldt RJ, van Leeuwen PAM, Hofman Z, M’Rabet L, De Bont DBA, van Norren K. Accurate prediction of xanthine oxidase inhibition based on the structure of flavonoids. Eur J Pharmacol 2002;451:111.PubMedCrossRef van Hoorn DEC, Nijvldt RJ, van Leeuwen PAM, Hofman Z, M’Rabet L, De Bont DBA, van Norren K. Accurate prediction of xanthine oxidase inhibition based on the structure of flavonoids. Eur J Pharmacol 2002;451:111.PubMedCrossRef
6.
Zurück zum Zitat Schnorr O, Brosette T, Momma TY, Kleinbongard P, Keen CL, Schroeter H, Sies H. Cocoa flavanols lower vascular arginase activity in human endothelial cells in vitro and in erythrocytes in vivo. Arch Biochem Biophys 2008;476:211.PubMedCrossRef Schnorr O, Brosette T, Momma TY, Kleinbongard P, Keen CL, Schroeter H, Sies H. Cocoa flavanols lower vascular arginase activity in human endothelial cells in vitro and in erythrocytes in vivo. Arch Biochem Biophys 2008;476:211.PubMedCrossRef
7.
Zurück zum Zitat Barnes PJ. Defective antioxidant gene regulation in COPD: a case for broccoli. Am J Respir Crit Care Med 2008;178:552.PubMedCrossRef Barnes PJ. Defective antioxidant gene regulation in COPD: a case for broccoli. Am J Respir Crit Care Med 2008;178:552.PubMedCrossRef
Metadaten
Titel
Tomato Extract for Hypertension?
Editorial to “The Effects of Natural Antioxidants from Tomato Extract in Treated but Uncontrolled Hypertensive Patients” by E. Paran et al.
verfasst von
Peter W. de Leeuw
Aalt Bast
Publikationsdatum
01.04.2009
Verlag
Springer US
Erschienen in
Cardiovascular Drugs and Therapy / Ausgabe 2/2009
Print ISSN: 0920-3206
Elektronische ISSN: 1573-7241
DOI
https://doi.org/10.1007/s10557-008-6161-4

Weitere Artikel der Ausgabe 2/2009

Cardiovascular Drugs and Therapy 2/2009 Zur Ausgabe

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

PET kann infarktgefährdete Koronararterien entdecken

04.06.2024 Koronare Herzerkrankung Nachrichten

Der Nachweis aktiver Plaques mittels 18F-Natriumfluorid-PET hilft nicht nur, infarktgefährdete Patienten, sondern auch infarktgefährdete Koronararterien zu erkennen. Von einer gezielten Behandlung vulnerabler Plaques ist man trotzdem weit entfernt.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.